Codiak BioSciences, Inc.
Codiak BioSciences, Inc. (CDAK) Stock Overview
Explore Codiak BioSciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-0.03
EPS (TTM)
$-0.46
ROE
-1.22%
CDAK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Codiak BioSciences, Inc. (CDAK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.02.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.